Our Story
Organ Transport Systems, Inc. (“OTS”) was founded in Houston, Texas in mid-1999 by Hyman P. White. Earlier that year, he
had been approached by shareholders of International Organ Transport Systems, Inc. who sought to turnaround their fledgling
company whose purpose was to commercialize an organ preservation technology conceived at the University of Texas Health
Science Center at San Antonio.
Read More
Our Products
LifeCradle® systems consist of a durable perfusion unit and the complimenting single-use, organ chamber and fluid circuit kit. The LifeCradle® is patented in the U.S. with additional patents either granted or pending internationally.
The LifeCradle® HR
Cardiac Perfusion System is specifically designed for heart perfusion. With eight years of pre-clinical research and experience, it is planning to enter into clinical trials in 2012.
The LifeCradle® LI
Hepatic Perfusion System will perfuse livers for transplantation and is in initial stages of development.
The LifeCradle® KI
Renal Perfusion System will perfuse kidneys for transplantation and is in initial stages of development.
The LifeCradle® LU
Pulmonary Perfusion System will perfuse lungs for transplantation and is in initial stages of development.